Reducing Edema After intraCerebral Hemorrhage
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.
Also called NCT05263167
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT05263167
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT05263167. Randomized; quadruple masking; primary purpose treatment. Start 2022-03-15 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Reducing Edema After intraCerebral Hemorrhage
- Condition
- Edema Brain
- Intervention (Drug)
- Sodium Aescinate
- Intervention (Drug)
- Placebo
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct05263167- Content hash
f25d05688ea6931a573e34d60bd89a25ec0f5f16d7a7f40e4b0534a39f6a771e